· Venture Capital Tracker · investment-strategies  · 2 min read

NYC Series A in 2026: Data-Backed Benchmarks on Metrics, Valuations, and Timelines

A Series A in NYC 2026 typically requires $1-5M ARR (SaaS) or equivalent traction. Valuations range $40-150M post-money. Here's the data.

NYC Series A is a specific stage with specific expectations. Here’s what the data says.

The Series A baseline (2026)

  • Round size: $10–25M typical; $25–50M for AI-native technical teams.
  • Post-money valuation: $40–150M; AI-native can push $150M+.
  • Investment period: Deploy over 18–24 months.
  • Board seat: Lead investor takes board seat; some rounds include 1 independent.

Metric benchmarks by sector (NYC Series A)

B2B SaaS

  • ARR: $1–5M for most rounds; $3–10M for competitive.
  • Growth rate: 100–200% YoY.
  • NRR: > 110%.
  • Gross margin: 70%+.
  • CAC payback: under 24 months.
  • Burn multiple: under 2x (net new ARR / net burn).

Fintech

  • Revenue or GTV: $3M+ ARR or $100M+ GTV annualized.
  • Unit economics: Clear path to profitability.
  • Regulatory posture: No material compliance risk.
  • Customer profile: Evidence of enterprise or SMB repeatability.

Marketplace

  • GMV: $5M+ annualized.
  • Take rate: Sustainable and growing.
  • Network density: Strong in initial geography/category.
  • Cohort retention: Improving over time.

Consumer

  • Revenue / DAU / MAU: Depends on model.
  • Retention curves: Flattening after initial drop.
  • CAC / LTV: Clear positive economics.
  • Virality or repeat: Organic growth component.

Health tech

  • Revenue or usage: $1M+ ARR or 10K+ active users.
  • Regulatory readiness: FDA pathway or HIPAA compliance clear.
  • Payer / provider mix: Defined GTM path.

Top NYC Series A leads in 2026

  • Primary Venture Partners — for NYC-based companies at Series A.
  • Thrive Capital — category-leader stage.
  • FirstMark Capital — enterprise/consumer generalist.
  • Insight Partners (Growth) — for more mature Series A ($8M+ ARR).
  • Bessemer Venture Partners (NYC office) — SaaS strength.
  • Accel (NYC presence) — growth-ready software.
  • Lightspeed Venture Partners (NYC deals).
  • RRE Ventures.
  • Greycroft — consumer, fintech, media.

The Series A process (NYC 2026)

Weeks 0–4: Prep, investor list, warm intros. Weeks 5–10: First meetings (10–20), second meetings (5–10). Weeks 11–14: Partner meetings (3–5), reference checks. Weeks 15–18: Term sheet, negotiation. Weeks 19–24: Close, legal, funding.

Total: 4–6 months from kickoff to funded for a competitive process.

What fails NYC Series A rounds

  1. ARR but no retention: High churn kills Series A even with growth.
  2. Founder conflicts: Board-ready teams win; fragmenting teams don’t.
  3. Cap table issues: Unresolved SAFE stack, bad early grants.
  4. Regulatory shadow: Compliance uncertainty disqualifies many fintech and health deals.
  5. TAM story weakness: NYC investors demand bottoms-up TAM.

Practical takeaway

  • Founders: Start Series A conversations 6 months before your raise with 18 months of runway remaining.
  • Investors: Series A pricing has stabilized post-2022; discipline on valuation is back.
  • LPs: NYC Series A quality remains strong despite headline deal-count softness.

Sources

  1. AlleyWatch NYC VC reports: https://www.alleywatch.com/
  2. Carta Q4 2025 VC performance: https://carta.com/data/vc-fund-performance-q4-2025/
  3. Pitchbook-NVCA Q4 2025: https://nvca.org/wp-content/uploads/2026/01/q4-2025-pitchbook-nvca-venture-monitor.pdf

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »